|
ABTB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.969220E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.383830E-04 |
| Normal-vs-Stage2 |
7.200100E-04 |
| Normal-vs-Stage3 |
5.621100E-03 |
| Normal-vs-Stage4 |
1.317930E-02 |
| Stage1-vs-Stage2 |
7.055400E-01 |
| Stage1-vs-Stage3 |
3.033200E-01 |
| Stage1-vs-Stage4 |
8.261400E-01 |
| Stage2-vs-Stage3 |
5.730200E-01 |
| Stage2-vs-Stage4 |
6.795600E-01 |
| Stage3-vs-Stage4 |
4.585600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.645380E-04 |
| Normal-vs-AfricanAmerican |
8.170500E-04 |
| Normal-vs-Asian |
6.181600E-02 |
| Caucasian-vs-AfricanAmerican |
4.380000E-01 |
| Caucasian-vs-Asian |
8.854400E-01 |
| AfricanAmerican-vs-Asian |
7.254400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.012730E-04 |
| Normal-vs-Female |
1.920670E-03 |
| Male-vs-Female |
6.311900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.230500E-04 |
| Normal-vs-Extreme_Weight |
1.361750E-04 |
| Normal-vs-Obese |
4.437100E-04 |
| Normal-vs-Extreme_Obese |
6.386500E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.441600E-01 |
| Normal_Weight-vs-Obese |
7.928200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.099200E-01 |
| Extreme_Weight-vs-Obese |
4.357000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.396800E-01 |
| Obese-vs-Extreme_Obese |
7.260400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.064990E-01 |
| Normal-vs-Age(41-60Yrs) |
3.032500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.027780E-04 |
| Normal-vs-Age(81-100Yrs) |
3.442000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.990100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.395900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.094960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.463000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.404200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.648600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.01840000000542E-05 |
| Normal-VS-Type2 PRCC |
1.460330E-03 |
| Normal-VS-KIRP CIMP |
7.517800E-01 |
| Normal-VS-Unclassified PRCC |
3.363500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.058300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.489630E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.178200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.924400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.028600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.146400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04169999999948E-05 |
| Normal-vs-N1 |
1.380890E-03 |
| Normal-vs-N2 |
4.974600E-01 |
| N0-vs-N1 |
1.824580E-01 |
| N0-vs-N2 |
3.561800E-01 |
| N1-vs-N2 |
3.182600E-01 |
|
|
